Results 31 to 40 of about 65,612 (263)

Drug shortages in low- and middle-income countries: Colombia as a case study

open access: yesJournal of Pharmaceutical Policy and Practice, 2022
Background Drug shortages are a global problem. Analyzing shortages worldwide is important to identify possible relationships between drug shortages across countries, determine strategies that reduce drug shortages, and reduce the inequality in access to
Martha L. Sabogal De La Pava   +1 more
doaj   +1 more source

Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? A Retrospective Analysis of Switzerland 2015-2020

open access: yes, 2022
Objectives: We analyze how shortages led to changes in access to and expenditure for pharmaceutical care in the Swiss health system between 2015 and 2020. Methods: We combined cross-sectional and longitudinal data to study medicine shortages by incidence,
Blankart, Katharina E., Felder, Stefan
core   +1 more source

Evaluating maternal health capacity building in rural and underserved areas: a research protocol

open access: yesRural and Remote Health, 2023
Introduction: The US is currently experiencing a maternal health crisis. Maternal morbidity and mortality in the US are higher than in other developed nations and continue to rise.
Robert Owens   +8 more
doaj   +1 more source

Examining the impact of resilience strategies in mitigating medicine shortages in the United Kingdom's (UK) pharmaceutical supply chain (PSC) [PDF]

open access: yes, 2023
Purpose: Medicine shortages have a detrimental impact on stakeholders in the pharmaceutical supply chain (PSC). Existing studies suggest that building resilience strategies can mitigate the effects of these shortages.
Yaroson, E.V.   +4 more
core   +1 more source

Results of EAHP’s 2018 Survey on Medicines Shortages [PDF]

open access: yesEuropean Journal of Hospital Pharmacy, 2019
The aim of the 2018 EAHP Survey on Medicines Shortages was to provide a clearer picture on the issue of medicines shortages, including the impact on hospital pharmacists' time, budgets and the effect on patient care.A survey was conducted by the EAHP, collecting information from European hospital pharmacists on the shortage situation in their ...
Danzon, Patricia M.   +44 more
openaire   +3 more sources

Results of EAHP’s 2019 Medicines Shortages Survey [PDF]

open access: yesEuropean Journal of Hospital Pharmacy, 2020
The aim of the 2019 EAHP Medicines Shortages Survey was to collect information on reasons and management strategies for medicines shortages as well as details on their impact on patients. The survey targeted hospital pharmacists (HPs), physicians (PHYs), nurses (NRS) and other healthcare professionals (OHCPs).
Nenad Miljković   +4 more
openaire   +2 more sources

Facemask Alternatives in Veterinary Medicine in the Context of COVID-19 Shortages

open access: yesFrontiers in Veterinary Science, 2020
The COVID-19 pandemic has caused a widespread shortage of facemasks and other personal protective equipment in veterinary medicine without clear, research-based guidance on alternatives to FDA-certified disposable surgical masks.
Abigail Gavra Michaelson Purens   +1 more
doaj   +1 more source

Shortages of medicines: a complex global challenge

open access: yesBulletin of the World Health Organization, 2012
6,7 A recent commentary in a Belgian pharmacy journal claims that the problem is global – “from Afghanistan to Zimbabwe” – listing 21 countries affected by a variety of supply problems. 8 A shortage of the injectable antibiotic streptomycin was reported in 15 countries in 2010, with 11 more countries predicting their stocks would run out before they ...
Andy Gray, Henri R Manasse Jr
openaire   +4 more sources

Do medicine shortages reduce access to care and increase pharmaceutical expenditure? A retrospective analysis of Switzerland 2015‒2020

open access: yes, 2021
Objectives The number of medicines reported under short supply has increased. We analyze how shortages led to changes in access to and expenditure for pharmaceutical care in the Swiss health system between 2015 and 2020.
Stefan Felder, Katharina Blankart
core   +1 more source

The impact of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) to address shortages of human and veterinary medicines across Europe

open access: yesFrontiers in Public Health
Shortages of medicines are a global public health challenge with a significant impact on patient care. While the issue is at the top of the agenda of EU policymakers, regulators and healthcare providers, shortages are a complex problem with many ...
Inga Abed   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy